Development of an artificial intelligence software to detect interstitial pneumonias

Background: Interstitial pneumonias (IPs) are commonly intractable diseases with poor prognosis. Recently, antifibrotic agents are developed against idiopathic pulmonary fibrosis (IPF) which is the most common phenotype of IPs and early use is recommended to restrain deterioration of the respiratory function and prevent the acute exacerbation. However, it is challenging to find patients with IPs in their early stage with the chest X-ray...